Tag: Ibd

An important guideline for individuals with colitis is to avoid over-the-counter (OTC) antidiarrheals, including Pepto Bismol, unless specifically advised by a healthcare provider. The use of bismuth subsalicylate in some inflammatory conditions can carry significant risks, emphasizing the critical question: **Can Pepto Bismol help colitis?**

While prednisone is a powerful anti-inflammatory medication, studies on Inflammatory Bowel Disease (IBD) patients have repeatedly shown that fecal calprotectin levels can remain elevated despite clinical improvement with glucocorticoid therapy. This raises a critical question for many patients and clinicians: can prednisone cause high calprotectin, or is there another explanation for the test result?

Recent studies suggest that Ozempic (semaglutide), a medication for type 2 diabetes and weight management, is generally considered safe for people with Inflammatory Bowel Disease (IBD). However, patients considering whether they **can you take Ozempic if you have inflammatory bowel disease?** should understand the nuances of managing its common gastrointestinal side effects alongside their existing condition.

Studies have shown that nonsteroidal anti-inflammatory drug (NSAID) use is associated with a 17%–28% relapse rate in people with quiescent inflammatory bowel disease (IBD) [1.3.3]. Understanding **what medicines should I avoid with Crohn's** is a critical part of managing the condition and preventing symptom flare-ups.

For some patients with Crohn's, symptom relief with infliximab can begin within as little as 2 to 3 days after the initial dose. However, this is not a universal experience, and the timeline for how long do biologics take to work for Crohn's can vary significantly between individuals and medications.

According to the Crohn's & Colitis Foundation, many patients with Crohn's disease may experience a loss of response to their medication over time. Understanding what is an alternative to Humira for Crohn's disease is therefore an important part of long-term disease management for many individuals.

For up to 40% of Crohn's disease patients, anti-TNF biologics either fail to work initially or lose their effectiveness over time. This can be a discouraging setback, leaving many to wonder **what happens if biologics don't work for Crohn's** and what their next options are.

According to a 2025 study, GLP-1 medications like semaglutide were found to be effective for weight loss in people with inflammatory bowel disease (IBD), with a safety profile comparable to those without IBD. Yet, the question remains: Can you take weight loss injections with Crohn's disease, given its potential for severe gastrointestinal side effects?.

Affecting nearly half a million people in the United States, Crohn's disease presents a significant treatment challenge. This raises a critical question for many patients and clinicians: Is upadacitinib effective in the real-world for Crohn's disease?

In the United States, Crohn's disease affects as many as 780,000 people, a chronic inflammatory condition requiring long-term management. For many, the question is, **is methotrexate good for Crohn's?** This immunomodulator is a key option, particularly for maintaining remission and reducing steroid dependence.